A virus that most people associate with a painful skin rash is revealing itself to be something far more consequential. Research now shows that shingles — caused by the same varicella-zoster virus that produces chickenpox in childhood — significantly elevates the risk of stroke and heart attack, particularly in the days and weeks immediately following infection. The danger is not a distant afterthought but appears concentrated in the acute phase itself, suggesting the infection actively disrupts the vascular system rather than merely leaving it weakened. As medicine begins to see shingles as a
Shingles linked to stroke and heart attack risk, studies show
The virus reaches far beyond the skin and affects the organs that keep us alive.
Mark
So shingles causes a rash. Why would that affect the heart or brain?
Mimi
The rash is just what you see on the surface. The virus itself triggers inflammation throughout the body, and that inflammation can damage blood vessels and promote clotting. It's not the rash doing the damage—it's the viral infection.
Luke
But how strong is this evidence? Are we talking about a small increase in risk, or something substantial?
Mimi
The research shows measurable elevation in stroke risk, especially in the days and weeks right after infection. That's the key finding—it's not a distant, theoretical risk.
Mark
Who's most at risk? Everyone who gets shingles, or certain people?
Mimi
Anyone can get shingles if they've had chickenpox, but people with existing heart or stroke risk factors are probably more vulnerable to these complications.
Luke
The article mentions the evidence is "strongest for stroke." What about heart attacks? Is that less clear?
Mimi
Heart attacks have been linked in studies too, but stroke is where the data is most consistent and convincing right now.
Mark
So what should someone do if they get shingles?
Mimi
Get treated with antivirals quickly, manage the pain, and if you have cardiovascular risk factors, probably get closer medical monitoring during the acute infection.
Luke
Is there any evidence that the shingles vaccine reduces this cardiovascular risk, or is that still unknown?
Mimi
That's an open question. The vaccine prevents shingles, which would prevent the infection entirely, but whether it has direct cardiovascular benefits beyond that—we don't know yet.
O Pulso
- A virus long dismissed as a painful but manageable skin condition is now linked to a measurably higher risk of stroke and heart attack across broad populations.
- The danger is most acute during the active infection window — the very days the rash is visible — meaning the threat arrives faster than most patients or doctors anticipate.
- Inflammation, disrupted blood vessels, and activated clotting cascades are among the proposed mechanisms, with those carrying existing cardiovascular risk factors facing the sharpest exposure.
- Clinicians are beginning to rethink post-shingles care, considering closer vascular monitoring for patients during and after infection rather than treating it as a skin-and-nerve problem alone.
- The shingles vaccine, already recommended for older adults, is now being examined for whether it may offer cardiovascular protection beyond simply preventing the rash.
A virus that most people associate with a painful skin rash is revealing itself to be something far more consequential. Research now shows that shingles — caused by the same varicella-zoster virus that produces chickenpox in childhood — significantly elevates the risk of stroke and heart attack, particularly in the days and weeks immediately following infection. The danger is not a distant afterthought but appears concentrated in the acute phase itself, suggesting the infection actively disrupts the vascular system rather than merely leaving it weakened. As medicine begins to see shingles as a systemic cardiovascular threat, the question of how we monitor, treat, and prevent it takes on new urgency.
The blistering, one-sided rash of shingles is painful enough on its own — often followed by months of nerve pain long after the skin heals. But recent research is revealing that the varicella-zoster virus, which causes shingles after lying dormant in nerve tissue for years or decades, does not confine its damage to the surface. Studies are increasingly linking shingles infection to a significantly elevated risk of stroke and heart attack.
The connection is strongest for stroke, and the timing is telling. The elevated risk appears not in some distant aftermath, but during the acute phase itself — the days and weeks when the rash is active and the immune system is in full response. Researchers have proposed several mechanisms: widespread inflammation, disruption to blood vessel walls, and the activation of clotting pathways. For those already carrying risk factors like age, high blood pressure, or prior heart disease, a shingles infection may be enough to tip a precarious balance.
Dr. Abi Manesh of Christian Medical College in Vellore notes that the vascular evidence is accumulating across multiple studies, making this more than a rare complication — it is a measurable population-level risk affecting thousands each year. The clinical picture is shifting accordingly. Shingles can no longer be managed as simply a painful skin condition. Patients, especially those with cardiovascular vulnerabilities, may need closer monitoring during and after infection.
The findings also cast the shingles vaccine in a new light. Already recommended for older adults to prevent the rash and its nerve complications, the vaccine may carry an additional benefit: reducing the window of vascular vulnerability that the infection opens. As research continues to accumulate, the image of shingles as a localized nuisance is giving way to something more sobering — a dormant virus capable, when it wakes, of reaching the organs that keep us alive.
The rash that comes with shingles is unmistakable—painful, blistering, confined to one side of the body. Most people who get it know to expect weeks of discomfort, sometimes months of lingering nerve pain long after the skin heals. What they may not know is that the virus behind shingles does not stop at the skin. Recent research has begun mapping a connection between shingles infection and a sharply elevated risk of stroke and heart attack, particularly in the vulnerable window of days and weeks immediately following the acute illness.
Shingles is caused by the varicella-zoster virus, the same pathogen responsible for chickenpox. After chickenpox resolves, the virus lies dormant in nerve tissue. Years or decades later, it can reactivate as shingles. The reactivation triggers the characteristic rash, but scientists are now asking what else it triggers in the body. The answer, emerging from multiple studies, points to the cardiovascular system.
Dr. Abi Manesh, an associate professor in the infectious diseases department at Christian Medical College in Vellore, notes that the evidence linking shingles to vascular complications is strongest for stroke. The risk appears to be highest not months later, but in the acute phase itself—during the days and weeks when the rash is active and the body is mounting an immune response to the virus. This timing matters. It suggests the infection itself, not some lingering aftermath, is driving the increased danger.
The mechanism is not yet fully understood, but researchers have proposed several pathways. Viral infection can trigger inflammation throughout the body, including in blood vessels. It can also activate clotting cascades. For someone already carrying risk factors—age, high blood pressure, diabetes, prior cardiovascular disease—a shingles infection may tip the balance. Even for those without obvious risk factors, the virus appears to create a temporary but significant window of vulnerability.
Heart attacks have also been linked to shingles in the research literature, though the evidence for stroke is more robust. The pattern is consistent: infection followed by elevated risk, with the danger concentrated in the immediate aftermath. This is not a rare complication affecting a handful of people. The studies suggest the risk is measurable across populations, which means it affects thousands of people each year who develop shingles.
The clinical implications are beginning to shift how doctors think about shingles management. It is no longer simply a painful skin condition to be treated with antivirals and pain relief. Understanding shingles as a systemic threat to vascular health means patients may need closer monitoring during and after infection, particularly those with existing cardiovascular risk factors. It also raises questions about prevention—whether vaccination against shingles, already recommended for older adults, might carry additional cardiovascular benefits beyond preventing the rash itself.
For now, the research continues to accumulate. Each study adds another piece to the picture of how a virus that hides in nerve tissue for decades can, when it emerges, reach far beyond the skin and affect the organs that keep us alive.
Citações Notáveis
Evidence is strongest for stroke, particularly in the days and weeks after a shingles episode— Dr. Abi Manesh, associate professor of infectious diseases, Christian Medical College, Vellore
Quer a matéria completa?
Leia o original em Times of India ↗
Health & Medicine